Classifying the estrogen receptor status of breast cancers by expression profiles reveals a poor prognosis subpopulation exhibiting high expression of the ERBB2 receptor.
Hum Mol Genet. 2003 Dec 15;12(24):3245-58. doi: 10.1093/hmg/ddg347. Epub 2003 Oct 21.
Hum Mol Genet. 2003.
PMID: 14570715